Clinical trial
A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma
NCT01730222 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- August 31, 2017
- Enrollment
- 137 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer